BDBM430846 (3-(5-methylthiazol-4-yl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)(4-(thiophen-2-yl)phenyl)methanone::US10544150, Compound 275

SMILES Cc1scnc1-c1nnc2CN(CCn12)C(=O)c1ccc(cc1)-c1cccs1

InChI Key InChIKey=BERNGXJDXZUQTJ-UHFFFAOYSA-N

Data  1 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 430846   

TargetNeuromedin-K receptor(Human)
Ogeda

US Patent
LigandPNGBDBM430846((3-(5-methylthiazol-4-yl)-5,6-dihydro-[1,2,4]triaz...)
Affinity DataKi: >5.00E+3nMAssay Description:The ability of the compounds of the invention to inhibit the binding of the NK-3 receptor selective antagonist SB222200 was assessed by an in vitro r...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/20/2020
Entry Details
US Patent